A Prospective RSA and Clinical Evaluation of the Trident II Acetabular Cup
NCT ID: NCT03261986
Last Updated: 2020-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2017-06-09
2022-02-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fixation and Stability of the Trident® II Clusterhole HA Shells
NCT03724058
A Register Based Prospective Study During Implementation of a New Cup
NCT04350255
RSA Study Using Two Types of Uncemented Acetabular Components and the Uncemented HA Coated Symax Stem
NCT01618084
Nexus Evaluation Primary Trident II Uncemented Shell
NCT05366712
Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty
NCT03897595
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trident II acetabular cup
Subjects receive the Trident II acetabular cup and RSA beads and undergo a series of post-operative RSA exams.
Radiostereometric Analysis
RSA exams of the operative hip are received post-op day 1, and at 6 weeks, 3 months, 6 months, 1 year and 2 years following surgery
total hip arthroplasty with RSA bead implantation
Patients receive RSA beads inserted into the bone surrounding the Trident II implant.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiostereometric Analysis
RSA exams of the operative hip are received post-op day 1, and at 6 weeks, 3 months, 6 months, 1 year and 2 years following surgery
total hip arthroplasty with RSA bead implantation
Patients receive RSA beads inserted into the bone surrounding the Trident II implant.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Scheduled to undergo a primary total hip arthroplasty
3. Patient is a candidate for the Trident II acetabular cup in accordance with product labeling -
Exclusion Criteria
2. Severe hip dysplasia (Crowe Type III or IV) in the affected hip
3. History of congenital dislocation
4. Prior arthroplasty of the affected hip
5. Active or prior infection of the affected hip
6. Morbid obesity (BMI \> 40)
7. Medical condition precluding major surgery
8. Severe osteoporosis
9. Neuromuscular impairment
10. Patients with known allergy to metals
11. Pregnancy
12. Patients on dialysis or creatinine \> 2.0
13. Patient is immuno-suppressed -
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Midwest Orthopaedics at Rush
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Sporer, MD
Role: PRINCIPAL_INVESTIGATOR
Midwest Orthopaedics at Rush
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Midwest Orthopaedics at Rush
Naperville, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-066
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.